Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry
about
Evidence for DNA damage as a biological link between diabetes and cancerWhat can we learn from the recent blood glucose lowering megatrials?From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management programAssociations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.Validation of methods to control for immortal time bias in a pharmacoepidemiologic analysis of renin-angiotensin system inhibitors in type 2 diabetes.Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registryEvaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients.Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.A summary risk score for the prediction of Alzheimer disease in elderly personsUsing a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis.The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study.Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Predictive Mortality Index for Community-Dwelling Elderly Koreans.Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus.Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engineIndependent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitusPrediction of morbidity and mortality in patients with type 2 diabetesAldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients.Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry.Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registryInteractive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program.Pregnancy and diabetes scenario around the world: China.Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome.A four-year cardiovascular risk score for type 2 diabetic inpatients.Clinical characteristics of Chinese patients with duration of type 2 diabetes >40 years.A Point-based Mortality Prediction System for Older Adults with Diabetes.Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study.Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.A transient improvement in renal function occurs after ischemic stroke.Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes
P2860
Q27001226-E02EDD0E-892B-4348-BDCF-A0FD56C85225Q33558383-F40906CE-6429-4734-8F4E-21055277F52AQ33577432-34FD8D0B-F9A9-48BD-8240-BA73DD66294AQ33803499-B758BC15-A948-41DC-96E9-FAC93FD81E38Q33819587-A084AB3E-9D6B-49F3-B8FB-2B02E3048C4EQ34116963-2DAA6678-F008-4CF2-949E-2048D98F9002Q34502293-172C5A50-FB63-4933-8356-D555D07EB038Q34507157-45ED06C7-754D-4DBE-A4E6-93920157EFE8Q34747831-B4196D29-6481-44F9-B3EB-754E7BF48385Q34859942-A45792F0-DC0F-44FF-9CA3-B8A2802693A4Q34893020-494F52A3-7717-4016-926B-BE3C0800D43EQ35077910-E90CFDCE-4590-4170-88C8-7A4249521112Q35814812-51303C7A-3EC9-40AB-B9C3-5DB0B55E6CA7Q35976486-A883000B-4B8A-4A81-87A1-31B69232A58DQ36390585-83C8985C-A48E-43BF-BCA4-AA0779B42E66Q36566995-82D4E100-4871-45BB-A792-C32A63B51DB3Q36649245-779D12D8-7E16-423C-9AC6-C9800F6B6427Q36782615-2A09A9F1-BEC0-46B5-A18E-6F9C24A61B5EQ36841591-4599E139-2EB0-4C58-AA0B-074E7BD1D6ECQ36936666-A533BB5E-3CDF-47EE-8D12-B7695459EB3CQ36945298-9626716A-1225-44DC-944A-8CCAD5FD8AB2Q36975675-1A70CC7A-9112-4494-B615-7A9923C5AA2EQ37106533-D6950F10-D9CC-437B-8415-FFCF63D95BCAQ37163138-4262BF14-0654-4BAD-A99A-8C802180293EQ37236318-6C7F412C-31FF-4C10-8372-9C06C7B16E03Q37364995-B59032A5-8C46-4517-B2B8-ECFB8CDD8E86Q37386378-B017105B-F3E3-4ED8-BE77-7AF34A42176BQ38627117-81EFDDBA-18DB-4698-8682-F1B8A73EFD78Q39983936-55B55A2D-4A36-40FC-98B6-3F3DAC35318DQ40009683-2147D758-6798-4B79-99F6-2B7EE7E1B30DQ40366831-401B1135-9393-4B96-B742-B25AFB3E568BQ40855717-6452505B-FD00-4D0B-A1EC-64CADADA6A21Q40985610-C5865447-2CAB-4643-AC35-B2B974D95A10Q42281548-A6D5AF42-A073-428A-8001-443D0F8270A8Q44107851-FBA3ABD2-367C-41D3-A41A-BE0F9DF22A21Q48209843-8C2F83D5-C8CE-44CA-B94D-23453E1B5677Q48327312-D9F1C299-9C6B-4809-B7B6-2021D45D9EBFQ48823339-CA16F8D6-3D32-48E2-8342-35F7C55FB590Q58209417-6C252D7B-2354-4319-BFF0-6E6FAFA688E4
P2860
Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry
description
article
@en
im März 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2008
@uk
name
Development and Validation of ...... he Hong Kong Diabetes Registry
@en
Development and Validation of ...... he Hong Kong Diabetes Registry
@nl
type
label
Development and Validation of ...... he Hong Kong Diabetes Registry
@en
Development and Validation of ...... he Hong Kong Diabetes Registry
@nl
prefLabel
Development and Validation of ...... he Hong Kong Diabetes Registry
@en
Development and Validation of ...... he Hong Kong Diabetes Registry
@nl
P2093
P1476
Development and validation of an all-cause mortality risk score in type 2 diabetes
@en
P2093
Alice P S Kong
Christopher W K Lam
Chun-Chung Chow
Chung Shun Ho
Clive S Cockram
Gary T C Ko
Hong Kong Diabetes Registry
Peter C Y Tong
Vivian C W Wong
Wing Yee So
P304
P356
10.1001/ARCHINTE.168.5.451
P407
P577
2008-03-01T00:00:00Z